SL-1002
N/A
Report date: 2025/11/11 20:00:28
Base Information
Drug NameSL-1002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSaol Therapeutics Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A